Skye Bioscience Financials - Benzinga

Skye Bioscience Inc

SKYENASDAQ

Trade with Public

Trade with Public

$1.86

0.084.49%

At close: Sep 4, 5:00 PM EST

$1.79

-0.07-3.76%

After Hours: Sep 4, 9:29 AM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

Skye Bioscience Financials

Skye Bioscience (SKYE) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Skye Bioscience Q1 EPS $(0.32) Misses $(0.31) Estimate

Skye Bioscience (NASDAQ:SKYE) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $(0.31) by 3.23 percent. This is a 14.29 percent decrease over losses of $(0.28) per share from

Benzinga Newsdesk

PRO
Skye Bioscience Q4 EPS $(0.36) Misses $(0.30) Estimate

Skye Bioscience (NASDAQ:SKYE) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate of $(0.30) by 21.21 percent. This is a 50 percent decrease over losses of $(0.24) per share from

Benzinga Newsdesk

Earnings Scheduled For March 10, 2026

Benzinga Insights

A Peek at Skye Bioscience's Future Earnings

Benzinga Insights

PRO
Skye Bioscience Q3 EPS $(0.32) Misses $(0.31) Estimate

Skye Bioscience (NASDAQ:SKYE) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $(0.31) by 1.91 percent. This is a 220 percent decrease over losses of $(0.10) per share from

Benzinga Newsdesk

Earnings Scheduled For November 10, 2025

Benzinga Insights